Paragon 28, Inc. Common Stock (FNA)
Frequently Asked Questions About Paragon 28, Inc. Common Stock (FNA)
How can investors stay informed about Paragon 28, Inc.?
Investors can stay informed about Paragon 28, Inc. by following the company's official website, where they provide press releases, investor relations updates, and financial reports. Additionally, interested investors can track the company's performance through financial news outlets, investor presentations, and earnings calls.
How does Paragon 28, Inc. engage with healthcare professionals?
Paragon 28, Inc. actively engages with healthcare professionals through educational initiatives, training programs, and participation in industry conferences. They seek to build strong partnerships with surgeons and medical institutions, providing them access to the latest surgical techniques and product updates to enhance patient care.
How does Paragon 28, Inc. prioritize innovation?
Paragon 28, Inc. prioritizes innovation by investing significantly in research and development to create groundbreaking surgical solutions. The company harnesses cutting-edge technologies and actively incorporates feedback from healthcare professionals, ensuring that their products remain at the forefront of medical advancements in foot and ankle care.
How many employees does Paragon 28, Inc. have?
As of the latest reports, Paragon 28, Inc. employs a growing team of professionals dedicated to various aspects of the business, including research and development, marketing, sales, and customer support. The company continues to expand its workforce as it grows in the competitive medical device market, although specific employee numbers may vary.
Is Paragon 28, Inc. publicly traded?
Yes, Paragon 28, Inc. is publicly traded on the New York Stock Exchange under the ticker symbol 'FNA'. The company went public through a merger with a special purpose acquisition company (SPAC), allowing it to raise capital for further product development and expansion within the medical device market.
What are some of the products offered by Paragon 28, Inc.?
Paragon 28, Inc. offers a comprehensive range of products for foot and ankle surgery, including but not limited to arthrodesis implants, surgical fixation systems, soft tissue repair solutions, and instrumentation. They are known for their innovative designs tailored to address specific clinical needs, thereby enhancing surgical precision and patient recovery.
What are some recent developments or announcements from Paragon 28, Inc.?
Recent developments from Paragon 28, Inc. often include product launches, collaborations with healthcare institutions, or advancements in clinical studies related to their offerings. The company keeps stakeholders updated through press releases and SEC filings, showcasing their progress and initiatives in the orthopedic medical device sector.
What are the growth prospects for Paragon 28, Inc.?
Paragon 28, Inc. has strong growth prospects driven by the increasing demand for foot and ankle surgical procedures and advancements in surgical technology. The company is focused on expanding its product portfolio and entering new markets, paving the way for continued revenue growth while addressing the evolving needs of orthopedic surgeons and their patients.
What are the key challenges facing Paragon 28, Inc.?
Key challenges facing Paragon 28, Inc. include navigating the competitive landscape of medical devices, addressing regulatory hurdles, and managing supply chain issues that can affect product availability. Additionally, sustaining innovation while ensuring affordability and accessibility of their offerings remains critical as they scale their operations.
What are the top competitors of Paragon 28, Inc.?
Paragon 28, Inc. faces competition from several established companies in the orthopedic medical device space, including Stryker, DePuy Synthes, and Zimmer Biomet. These competitors also offer a range of products for foot and ankle procedures, making the market highly competitive, with innovation and quality being key differentiators.
What does Paragon 28, Inc. do?
Paragon 28, Inc. is a medical device company specializing in foot and ankle surgical solutions. The company focuses on developing and providing advanced implants and technologies to support orthopedic surgeons in treating patients with a variety of foot and ankle conditions. Their products cater to both elective and trauma-related surgeries, with a notable emphasis on innovation and improvement of surgical outcomes.
What is the financial performance of Paragon 28, Inc.?
Paragon 28, Inc.'s financial performance has shown positive trends with steady revenue growth driven by an expanding product line and market demand. The company publishes its financial results quarterly, providing insights into its operating income, profit margins, and overall performance, which are critical for investors and stakeholders.
What is the mission of Paragon 28, Inc.?
The mission of Paragon 28, Inc. is to improve the quality of life for patients suffering from foot and ankle ailments by providing innovative, effective, and reliable surgical solutions. The company is committed to supporting healthcare professionals with educational resources and enhancing patient outcomes through their advanced product offerings.
What is the vision of Paragon 28, Inc.?
The vision of Paragon 28, Inc. is to be a leader in the orthopedic market, specifically in foot and ankle solutions, by delivering innovative, high-quality surgical products that improve patient outcomes. The company aims to continuously evolve its offerings and support healthcare professionals as they strive to provide the best possible care.
What is unique about Paragon 28, Inc.’s approach to product development?
Paragon 28, Inc. takes a surgeon-driven approach to product development, meaning they actively engage with orthopedic surgeons to identify unmet needs and co-develop solutions. This collaborative effort ensures that their products are designed with practical clinical input, focusing on usability, effectiveness, and enhancing surgical techniques.
What markets does Paragon 28, Inc. serve?
Paragon 28, Inc. primarily serves the orthopedic market, specifically focusing on foot and ankle surgery. Their products are utilized in hospitals and surgical centers across the United States and internationally, catering to both elective surgeries and trauma cases. This specialization allows them to build deep expertise and relationships within this niche market.
What regulatory approvals does Paragon 28, Inc. require for its products?
As a medical device company, Paragon 28, Inc. must obtain regulatory approvals from governmental agencies such as the U.S. Food and Drug Administration (FDA) before its products can be marketed and sold in the United States. These approvals ensure that the devices meet safety and efficacy standards necessary for patient use.
When was Paragon 28, Inc. founded?
Paragon 28, Inc. was founded in 2015 by a team of orthopedic professionals with extensive experience in the foot and ankle surgery market. The company was created to innovate surgical solutions that improve patient care, addressing the complexities and requirements inherent in foot and ankle procedures.
Where is Paragon 28, Inc. headquartered?
Paragon 28, Inc. is headquartered in Englewood, Colorado. This location serves as the central hub for the company's operations, including research, development, and management functions, allowing them to collaborate effectively with medical professionals and hospitals across the United States.
Who are the key executives at Paragon 28, Inc.?
The key executives at Paragon 28, Inc. include a diverse group of professionals with extensive experience in the medical device industry. This team is led by the CEO, who has a strong background in orthopedic surgical products, along with executive leaders overseeing product development, quality assurance, sales, and marketing functions to drive the company's vision forward.
What is the current price of Paragon 28, Inc. Common Stock?
The current price of Paragon 28, Inc. Common Stock is 13.08
When was Paragon 28, Inc. Common Stock last traded?
The last trade of Paragon 28, Inc. Common Stock was at 3:36 pm EDT on April 3rd, 2025